Insilico Increases Stake in Daesung Microbiological Labs to 39.24% via Open Market Purchase, Signaling Confidence
On June 2, 2026, Insilico purchased 8,688 common shares of Daesung Microbiological Labs at 6,642 won per share through open market transactions, increasing its stake from 39.01% to 39.24%.
The purchase price was at a slight premium to the current market price of 6,510 won, indicating management’s belief that the stock is undervalued.
[AI Summary]This minor increase in ownership by the largest shareholder is generally a positive signal, potentially supporting short-term stock price. However, the increment is too small to affect control or governance.
KOSDAQ Filing Information
Filing: Report on Ownership of Specific Securities by Executives and Major Shareholders